Your Gateway to the US Market
COME SEE US AT CPHI 2023, CONTACT US FOR MORE INFORMATION
GLOBAL PHARMAPARTNERS, INC YOUR BEST BUSINESS PARTNER FOR PHARMACEUTICAL SUCCESS!
Announcing: Tofacitinib Extended-Release Tablets - SUCCESSFUL BIOS!!!
GPP's Development Partner has developed Tofacitinib Extended Release Tablets USP, 11mg & 22 mg generic for XELJANZ XR (Tofacitinib citrate). We have successfully completed the U.S. pilot biostudy. Compete File ready for filing with FDA by May 2024. Also available for EU/UK/ROW. We have identified an FDA/EMA/MHRA inspected CMO and API. We are looking for US Commercial partner to take it forward. Please contact me at Robcamerer@globalpharmapartners.com or +1 (417) 770-4600
aboutus
GPP has developed valuable relationships over the last thirty years and has direct access to over 500 generic pharmaceutical sales and marketing companies in the USA, Canada, Latin America, and globally. GPP takes pride in nurturing relationships with the TOP decision makers at these companies.
2006
Established
13
Development Partners:
250+
US Clients:
Global Locations & Network
US Office:
4922 S. Eldon Avenue
Springfield, MO
65810 USA
Office: +1 (417) 885-7000
Mobile: +1 (417) 770-4600
Global Network:
Athens, Greece
Bejing, China
Dublin, Ireland
Hamburg, Germany
Lisbon, Portgual
London, England
Paris, France
Mumbai, India
New York, NY USA
Chicago, IL USA
Charlotte, NC USA
Tokyo, Japan
​
Our Expertise and Services
Marketing
GPP Markets to more than 250+ US customers both online as well as annually at DCAT, CPHi, as well as other marketing events
Design
GPP creates marketing materials for our partners for tradeshows and online campaigns
Our Products
CONTACT
US
VISIT
US
Upcoming trade shows:
EuroPLX 75 Cascias/Lisbon Virtual
Please contact us to schedule a meeting